中文名称：吉非替尼
  • N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺; 易瑞沙(阿斯利康公司的抗肿瘤新药); 吉非替尼(易瑞沙)
  • Iressa
  • GEFITINIB; AKOS 91371; n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine; N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine; ZD 1839; 4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-; Gefitinib(TINIBS); Gefitinib, Iressa, ZD1839; Gefitinib Base; Geftinib
  • 184475-35-2
  • C22H24ClFN4O3
  • 446.9024
  • InChI=1/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)
  • 吉非替尼 184475-35-2
  • 1.323g/cm3
  • 119-120
  • 586.755°C at 760 mmHg
  • 308.659°C
  • 0mmHg at 25°C